Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Happy holidays? Not necessarily in the pharmaceutical sector

Pharmaceutical manufacturers looking to cut costs need to keep focus on manufacturing/packaging to prevent product quality problems.

iStock_Pharma_bottles
iStock_Pharma_bottles

‘Tis the season to be jolly, right? Not necessarily in the pharmaceutical industry. A recent article from The Economist’s Intelligence Unit, for example, reported that Roche and Bayer were slashing thousands of jobs globally, attributing the cuts in part to industry consolidation, patent expires, and moving dollars to emerging markets.

It’s unclear if such job cuts will reach packaging staff at pharmaceutical companies, but one respected packaging veteran expressed concern to this editor that cutbacks could potentially affect packaging development (both new packages and packaging procedures), and operations (upgrades, safety, efficacy, recalls, etc.). This expert wondered if some of Johnson & Johnson’s problems could be traced to packaging and labeling errors resulting from cutbacks.

A recent Wall Street Journal online article noted, “Johnson & Johnson, which has been recalling a number of popular over-the-counter medicines, said it is withdrawing more Tylenol because of a labeling problem.” The recall of more than 9 million bottles, WSJ said, was being made “because the bottles’ front labels didn’t show they contain small amounts of alcohol from ingredients that flavor the medicine. …The recalls are costing the company hundreds of millions of dollars in lost sales and prompted the temporary shutdown of a key manufacturing plant and a revamp of manufacturing. The company has also shuffled management.”

The article said the labeling problem “doesn’t threaten the health of consumers, who don’t need to take action and can continue to take the product.” An unnamed contract manufacturer was said to have made the recalled products, according to the article.

The Economist’s piece concluded, “Job cuts that accompany a recession are understandable, and they are also reversible when better times come. But the shift into emerging markets, and away from the old sales and marketing routines, is more permanent. The jobs that are disappearing now will probably not reappear, though that may help to save other jobs by shoring up pharma company profits.”

Economic factors and strategic planning give a pharmaceutical industry veteran enough to be concerned about, but cutbacks in personnel that result in product quality issues could damage a company’s reputation and negatively impact the bottom line.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics